Catalogo dei prodotti della ricerca

VIZZA, Carmine Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.775
EU - Europa 3.207
AS - Asia 1.234
SA - Sud America 72
AF - Africa 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.699
IT - Italia 1.612
SG - Singapore 512
SE - Svezia 424
IN - India 385
UA - Ucraina 341
CN - Cina 243
FI - Finlandia 211
DE - Germania 143
GB - Regno Unito 125
FR - Francia 73
BG - Bulgaria 59
CA - Canada 51
TG - Togo 49
AR - Argentina 48
NL - Olanda 46
IE - Irlanda 41
RO - Romania 31
IR - Iran 22
MX - Messico 22
CH - Svizzera 19
HK - Hong Kong 19
BE - Belgio 17
LT - Lituania 15
BR - Brasile 9
RU - Federazione Russa 9
GR - Grecia 8
ES - Italia 7
MY - Malesia 7
TW - Taiwan 7
CL - Cile 6
CO - Colombia 6
TR - Turchia 6
AU - Australia 5
VN - Vietnam 5
EU - Europa 4
PL - Polonia 4
TH - Thailandia 4
AT - Austria 3
HR - Croazia 3
JP - Giappone 3
LB - Libano 3
PH - Filippine 3
PK - Pakistan 3
AZ - Azerbaigian 2
BD - Bangladesh 2
EG - Egitto 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ID - Indonesia 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
SI - Slovenia 1
Totale 11.354
Salva come PNG Salva come JPEG
Città #
Fairfield 931
Chandler 541
Woodbridge 476
Ashburn 438
Rome 438
Seattle 351
Cambridge 331
Singapore 314
Houston 296
Wilmington 296
Ann Arbor 291
Princeton 259
Dearborn 252
Plano 164
Beijing 145
Milan 120
Jacksonville 119
San Diego 116
San Paolo di Civitate 115
Boston 107
Lawrence 101
Millbury 89
Andover 60
Sofia 58
Des Moines 57
Santa Clara 54
Lomé 49
New York 47
Federal 45
Toronto 42
Dublin 40
Fremont 38
Boardman 37
Bremen 37
Helsinki 37
Norwalk 27
Southend 24
Groningen 20
Lappeenranta 20
Mannheim 19
San Mateo 19
Bühl 18
Brussels 17
London 17
Falls Church 16
Bergamo 15
Hefei 15
Leawood 15
Naples 14
Turin 14
Bari 13
Klaipėda 13
Kunming 13
Nanjing 11
Florence 10
Paris 10
Bologna 9
Grafing 9
Rende 9
Verona 9
Zanjan 9
Dallas 8
Padova 8
Puebla City 8
Amsterdam 7
Lowestoft 7
Torino 7
Cardito 6
Catania 6
Central 6
Jinan 6
Marino 6
Mexico City 6
Ottawa 6
Pune 6
Temuco 6
Treviso 6
Atlanta 5
Bogotá 5
Chengdu 5
Coyoacán 5
Custonaci 5
Genoa 5
Kuala Lumpur 5
Nanchang 5
Nocera Superiore 5
Phoenix 5
Riva del Garda 5
Stockholm 5
Taranto 5
Adelfia 4
Amandola 4
Athens 4
Balzola 4
Bonate Sotto 4
Brescia 4
Buffalo 4
Carrara 4
College Park 4
Formia 4
Totale 7.486
Salva come PNG Salva come JPEG
Nome #
Significato del sottoslivellamento del tratto ST nelle derivazioni precordiali in corso di infarto miocardico acuto della parete inferiore 712
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 118
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 105
Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients. a clinical trial 102
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 102
Right heart and pulmonary vessels structure and function 100
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging 97
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al 97
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 95
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 93
Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. 92
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 90
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 89
Human Herpesvirus 8 and Pulmonary Hypertension. 87
Right ventricular remodeling in idiopathic pulmonary arterial hypertension. adaptive versus maladaptive morphology 86
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 86
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension 85
Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. 82
Cardiovascular effects of chronic sildenafil in men with type 2 diabetes 81
Ambrisentan for the treatment of adults with pulmonary arterial hypertension. a review 81
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: Results of the COMPASS-1 study 80
Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis 80
Circulating biomarkers in pulmonary arterial hypertension. update and future direction 80
Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. 79
Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease 78
Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction 78
Mortality in pulmonary arterial hypertension. prediction by the 2015 european pulmonary hypertension guidelines risk stratification model 77
Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension. Cllinical impact and reversibility 77
Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function 74
Abnormal behavior of the forearm vasculature during ergometric test in hypertrophic cardiomyopathy 73
Response to letters regarding article, "anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)" 73
Pulmonary Arterial Dilatation in Pulmonary Hypertension: Prevalence and Prognostic Relevance 72
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 72
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 72
An official european respiratory society statement. pulmonary haemodynamics during exercise 72
Locoregional versus general anesthesia in carotid surgery: Is there an impact on peri-operative myocardial ischemia? Results of a prospective monocentric randomized trial. 71
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial 71
Identification of coronary artery by-pass grafts: reliability of MRI in clinical practice. 70
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial 70
Improved results with lung transplantation for cystic fibrosis 69
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 69
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension 69
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: Retrospective results from six European countries 69
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 68
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 68
Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension-Targeted Therapy The EURO-MR Study 68
Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction 68
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics 67
Usefulness of 2D echo Doppler in the preoperative assessment of cystic fibrosis patients who are candidates for lung transplantation 67
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 67
Timing and priorities for cystic fibrosis patients candidates to lung transplantation 66
Echo stress in functional evaluation of dilated cardiomyopathy. 66
Comparative Effects of Irbesartan Versus Amlodipine on Left Ventricular Mass Index in Hypertensive Patients with Left Ventricular Hypertrophy 66
Tissue viability by contrast echocardiography 66
Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. a pilot study in HFrEF patients 66
Efficacy of 1, 5, and 20mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension. a randomized, double-blind study with open-label extension 65
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension 65
Usefulness of the dipyridamole-Doppler test for diagnosis of coronary artery disease 64
Occult lung cancer in patients with bullous emphysema 63
Myocardial and micro-vascular inflammation/infection in HIV/HCV associated pulmonary artery hypertension 63
Heart failure pharmacological management. gaps and current perspectives 62
Unusual presentation for a patent ductus arteriosus 62
Preoperative evaluation of patients undergoing lung resection surgery. defining the role of the anesthesiologist on a multidisciplinary team 62
Cardiovascular effects of chronic sildenafil treatment in men with type 2 diabetes 62
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti con ?Diabete Mellito di tipo 2 61
Supravalvular aortic stenosis and pulmonary artery stenosis: echocardiographic and clinical aspects. 61
Assessment of right ventricular inotropic reserve during dobutamine infusion in patients with secondary pulmonary hypertension. 60
Pulmonary arterial hypertension: current therapies. 60
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): Safety, tolerability, clinical, and haemodynamic effect 60
Validità dell'ecocardiografia nella valutazione della terapia cardiovascolare 60
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial 60
Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation 60
Cardiac and vascular remodeling after 6 months of therapy with sacubitril/valsartan. mechanistic insights from advanced echocardiographic analysis 60
'Real-life' information on pulmonary arterial hypertension: The iPHnet Project 58
Safety and efficacy evaluation of ambrisentan in pulmonary hypertension 58
Endocrine and metabolic alterations in patients with pulmonary arterial hypertension 58
Hemodynamics during inhaled nitric oxide in lung transplant candidates 58
Endogenous opioid system modulation in anginal pain: demonstration of its central activity. 58
PROSTANOID THERAPY FOR PULMONARY ARTERIAL HYPERTENSION. 56
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 56
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 56
Dal Tromboembolismo Venoso all’Ipertensione Polmonare cronica tromboembolica 55
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. 55
Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias 55
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension 55
RESPITE. switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors 55
La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] 54
Isolated lung transplantation for end-stage lung disease 54
Reconstruction of the pulmonary artery by a conduit of autologous pericardium. 54
Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. 53
Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation 53
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 53
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. 52
Acute pulmonary vascular response to inhaled nitric oxide,dobutamine and their association in patients with secondary pulmonary hypertension. 52
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. 52
2019 ESC guidelines for the dignosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (ERS) 52
[Role of the endogenous opioid system in the modulation of anginal pain]. 51
Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: A case control study 51
Studio del tratto "ST" in pazienti sottoposti a TEA carotidea in anestesia locale o generale 51
The importance of right ventricular function in patients with pulmonary arterial hypertension 51
Totale 7.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.704 0 0 19 102 178 373 287 238 197 150 108 52
2020/20211.195 90 101 43 93 54 94 29 95 203 272 93 28
2021/20222.332 49 130 159 82 245 50 54 186 223 285 411 458
2022/20232.480 461 408 144 261 259 273 25 146 260 45 140 58
2023/20241.573 79 199 90 105 152 160 93 127 27 193 149 199
2024/2025485 135 214 136 0 0 0 0 0 0 0 0 0
Totale 11.925